Overview
Comparative Cycle Control Europe
Status:
Completed
Completed
Trial end date:
2006-09-01
2006-09-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The aim of this study is to evaluate bleeding pattern, cycle control, and safety of this new four-phasic oral contraceptive in comparison to a reference OC.Phase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Bayer
Criteria
Inclusion Criteria:- Healthy female volunteers aged between 18 and 50 years requiring contraception
Exclusion Criteria:
- Pregnancy or lactation
- Any conditions that might interfere with the outcome as well as all contraindications
for OC use